Corticotropin is a polypeptide hormone produced and secreted by the pituitary gland. Corticotropin acts through the stimulation of cell surface the adrenocorticotropic hormone (ACTH) receptors, which are primarily located on the adrenocortical cells. Corticotropin stimulates the cortex of the adrenal gland and boosts the synthesis of corticosteroids, mainly glucocorticoids but also sex steroids (androgens).
Corticotropin is indicated as monotherapy for the treatment of exacerbations of multiple sclerosis in adults and infantile spasms in infants and children under 2 years of age. Controlled clinical trials have shown Corticotropin to be effective in speeding the resolution of acute exacerbations of multiple sclerosis. However, there is no evidence that it affects the ultimate outcome or natural history of the disease. The mechanism of action of Corticotropin in the treatment of infantile spasms is unknown.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | ACTHAR Approved UseH.P. Acthar Gel is an adrenocorticotropic hormone (ACTH) analogue indicated as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age; H.P. Acthar Gel is indicated for the treatment of exacerbations of multiple
sclerosis in adults; H.P. Acthar Gel may be used for the following disorders and diseases: rheumatic; collagen; dermatologic; allergic states; ophthalmic; respiratory; and edematous state. Launch Date1950 |
|||
Primary | ACTHAR Approved UseH.P. Acthar Gel is an adrenocorticotropic hormone (ACTH) analogue indicated as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age; H.P. Acthar Gel is indicated for the treatment of exacerbations of multiple
sclerosis in adults; H.P. Acthar Gel may be used for the following disorders and diseases: rheumatic; collagen; dermatologic; allergic states; ophthalmic; respiratory; and edematous state. Launch Date1950 |
PubMed
Title | Date | PubMed |
---|---|---|
Cerebral atrophy following ACTH therapy. | 1980 Feb |
|
Sequential CT studies of 24 children with infantile spasms on ACTH therapy. | 1983 Aug |
|
Suppressive action of ACTH on growth hormone secretion in patients with infantile spasms. | 1985 |
|
ACTH and vasopressin responses to insulin-induced hypoglycemia in intact and neurohypophysectomized conscious dogs. | 1991 Jan |
|
Activity of adenosine deaminase in red blood cells of patients suffering from multiple sclerosis treated with adrenocorticotropic hormone. | 1995 Nov-Dec |
|
Effects of chronic 'Binge' cocaine administration on plasma ACTH and corticosterone levels in mice deficient in DARPP-32. | 1999 Sep |
|
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. | 2003 Jul |
|
Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure. | 2005 Dec 6 |
|
Partial 17alpha-hydroxylase/17,20-lyase deficiency-clinical report of five Chinese 46,XX cases. | 2008 Jul |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID60238185
Created by
admin on Sat Dec 16 12:51:31 GMT 2023 , Edited by admin on Sat Dec 16 12:51:31 GMT 2023
|
PRIMARY | |||
|
SUB01466MIG
Created by
admin on Sat Dec 16 12:51:31 GMT 2023 , Edited by admin on Sat Dec 16 12:51:31 GMT 2023
|
PRIMARY | |||
|
L0378Q1565
Created by
admin on Sat Dec 16 12:51:31 GMT 2023 , Edited by admin on Sat Dec 16 12:51:31 GMT 2023
|
PRIMARY | |||
|
16132264
Created by
admin on Sat Dec 16 12:51:31 GMT 2023 , Edited by admin on Sat Dec 16 12:51:31 GMT 2023
|
PRIMARY | |||
|
6967
Created by
admin on Sat Dec 16 12:51:31 GMT 2023 , Edited by admin on Sat Dec 16 12:51:31 GMT 2023
|
PRIMARY | |||
|
C169866
Created by
admin on Sat Dec 16 12:51:31 GMT 2023 , Edited by admin on Sat Dec 16 12:51:31 GMT 2023
|
PRIMARY | |||
|
471
Created by
admin on Sat Dec 16 12:51:31 GMT 2023 , Edited by admin on Sat Dec 16 12:51:31 GMT 2023
|
PRIMARY | |||
|
9050-75-3
Created by
admin on Sat Dec 16 12:51:31 GMT 2023 , Edited by admin on Sat Dec 16 12:51:31 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD